Open tender · Brazil · Public tender
Clobetasol 0,5MG Sol Capilar FR 50G e Outros
In EnglishCLOBETASOL 0.5mg HAIR SOLUTION FR 50G and others
Secretaria de Estado DA Saude in Brazil is inviting bids for “CLOBETASOL 0.5mg HAIR SOLUTION FR 50G and others”. Bids close on 13 October 2026, 08:00 GMT−3; the estimated value is R$4.51 million (framework maximum). Who can bid: Bidders must be registered in the SIADES system; Consortiums are not allowed to bid. askTender lists every requirement to qualify and checks whether your company meets them.
The tender in brief
A 1-year medicine supply contract for Espirito Santo state pharmacies, for registered medicine suppliers
The Espirito Santo State Health Secretariat will register prices for standardized medicines, including clobetasol scalp solution, insulin detemir and human immunoglobulin, to supply the State Citizen Pharmacies. The estimated maximum value is R$ 4.507.919,81. The price registry is valid for 1 year, extendable for an equal period.
Who can win it
- Bidders must be registered in the SIADES system
- Consortiums are not allowed to bid
- Companies sanctioned or with conflicts of interest cannot bid
Key facts
- Framework maximum
- R$4.51 million
- Procedure
- Pregão Eletrônico
- Contract period
- 1 year, extendable for an equal period
- How bids are judged
- Lowest price per item
- Published
- 29 Sep 2026
Before you bid, askTender
Everything else is in your askTender account
The requirements to qualify, the eligibility check and the bid documents for this tender are in your askTender account.
- What it takes to qualify: every requirement, in the tender’s own words
- Whether your company qualifies: your profile checked against each requirement, showing what you have, what’s missing and how to close the gap
- The documents to file: a checklist, with draft declarations ready to sign
- A bid partner for any requirement you can’t meet alone
- The tender documents, ready to open
- Alerts for new tenders like this one
Public data: Portal Nacional de Contratações Públicas. · Sources & licences